These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19611405)

  • 1. Human clearance prediction: shifting the paradigm.
    Lavé T; Chapman K; Goldsmith P; Rowland M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1039-48. PubMed ID: 19611405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.
    Obach RS; Baxter JG; Liston TE; Silber BM; Jones BC; MacIntyre F; Rance DJ; Wastall P
    J Pharmacol Exp Ther; 1997 Oct; 283(1):46-58. PubMed ID: 9336307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics.
    Iwatsubo T; Hirota N; Ooie T; Suzuki H; Sugiyama Y
    Biopharm Drug Dispos; 1996 May; 17(4):273-310. PubMed ID: 8845471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation.
    Fagerholm U
    J Pharm Pharmacol; 2008 May; 60(5):535-42. PubMed ID: 18416932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of hepatic metabolic clearance: comparison and assessment of prediction models.
    Zuegge J; Schneider G; Coassolo P; Lavé T
    Clin Pharmacokinet; 2001; 40(7):553-63. PubMed ID: 11510631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.
    De Buck SS; Sinha VK; Fenu LA; Gilissen RA; Mackie CE; Nijsen MJ
    Drug Metab Dispos; 2007 Apr; 35(4):649-59. PubMed ID: 17267621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using ontogeny information to build predictive models for drug elimination.
    Alcorn J; McNamara PJ
    Drug Discov Today; 2008 Jun; 13(11-12):507-12. PubMed ID: 18549977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data.
    Shou M
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):66-77. PubMed ID: 15679174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma.
    Brightman FA; Leahy DE; Searle GE; Thomas S
    Drug Metab Dispos; 2006 Jan; 34(1):94-101. PubMed ID: 16221756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human variability in hepatic and renal elimination: implications for risk assessment.
    Dorne JL
    J Appl Toxicol; 2007; 27(5):411-20. PubMed ID: 17497760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.